CompletedNot Applicable

Application of Ectoine Nasal Spray in Comparison With Cromolyn Sodium Containing Nasal Spray in Patients With Allergic Rhinitis

Germany50 participantsStarted 2009-05

Plain-language summary

This is a comparative, open label, parallel group, non interventional study to further demonstrate the effectiveness and tolerability of Ectoin Allergy Nasal Spray. In addition the effectiveness and safety shall be compared to a Cromoglycid acid containing nasal spray. The patient applies Ectoin Allergy Nasal Spray or Cromoglycid acid containing nasal spray according to the instructions for use. The observation takes place over a period of 14 days. Response to treatment is recorded at day 7 and day 14 by the physician and by the patient in a dairy at defined time intervalls.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Female or male individuals ≥ 18 years * Patients with proven Allergic Rhinitis which are treated with Ectoin Nasal Spray or -Cromoglycic acid nasal Spray during the observational period Exclusion Criteria: * Contra indications according to the label

What they're measuring

Change in combined nasal symptom Score

Timeframe: Time Frame: day 1, day 7, day 14

Trial details

NCT IDNCT02131038

SponsorBitop AG

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2009-09

View on ClinicalTrials.gov More Allergic Rhinitis trials